z-logo
Premium
HIP/PAP accelerates liver regeneration and protects against acetaminophen injury in mice
Author(s) -
Lieu HanhTu,
Batteux Frédéric,
Simon MarieThérèse,
Cortes Alexandre,
Nicco Carole,
Zavala Flora,
Pauloin Alain,
Tralhao José Guilherme,
Soubrane Olivier,
Weill Bernard,
Bréchot Christian,
Christa Laurence
Publication year - 2005
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.20845
Subject(s) - liver regeneration , medicine , liver injury , paracrine signalling , genetically modified mouse , cancer research , endocrinology , pathology , transgene , regeneration (biology) , biology , receptor , biochemistry , microbiology and biotechnology , gene
Human hepatocarcinoma‐intestine‐pancreas/pancreatic‐associated protein HIP/PAP is a secreted C‐type lectin belonging to group VII, according to Drickamer's classification. HIP/PAP is overexpressed in liver carcinoma; however, its functional role remains unclear. In this study, we demonstrate that HIP/PAP is a paracrine hepatic growth factor promoting both proliferation and viability of liver cells in vivo . First, a low number of implanted hepatocytes deriving from HIP/PAP‐transgenic mice (<1:1,000) was sufficient to stimulate overall recipient severe combined immunodeficiency liver regeneration after partial hepatectomy. After a single injection of HIP/PAP protein, the percentages of bromodeoxyuridine‐positive nuclei and mitosis were statistically higher than after saline injection, indicating that HIP/PAP acts as a paracrine mitogenic growth factor for the liver. Comparison of the early events posthepatectomy in control and transgenic mice indicated that HIP/PAP accelerates the accumulation/degradation of nuclear phospho–signal transducer activator transcription factor 3 and tumor necrosis factor α level, thus reflecting that HIP/PAP accelerates liver regeneration. Second, we showed that 80% of the HIP/PAP‐transgenic mice versus 25% of the control mice were protected against lethal acetaminophen‐induced fulminate hepatitis. A single injection of recombinant HIP/PAP induced a similar cytoprotective effect, demonstrating the antiapoptotic effect of HIP/PAP. Comparison of Cu/Zn superoxide dismutase activity and glutathione reductase‐like effects in control and transgenic liver mice indicated that HIP/PAP exerts an antioxidant activity and prevents reactive oxygen species‐induced mitochondrial damage by acetaminophen overdose. In conclusion , the present data offer new insights into the biological functions of C‐type lectins. In addition, HIP/PAP is a promising candidate for the prevention and treatment of liver failure. (H EPATOLOGY 2005;42:618–626.)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom